chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she had a fever of 102.8 for a couple of days; had a slight headache for a couple of days; a sore arm for a few days; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number: EN6205), via an unspecified route of administration, administered in Arm Left on 10Mar2021 21:40 (at the age of 60-year-old) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. She had no prior vaccination within 4 weeks. She had no adverse events prior to vaccination. The patient had a slight headache for a couple of days on 11Mar2021 then was good, a sore arm for a few days on 10Mar2021 stopped 3 or 4 days later and had recovered completely then was good. 12 days after the first dose on 22Mar2021 she had a fever of 102.7 on Monday and Tuesday then it started to trend down until Saturday on 27Mar2021. She saw the doctor on Thursday and since she had taken Advil for fever in the office her temperature was normal but an hour before her temperature was 101. She wanted to know if there was information on this and asked if she needed to delay her second dose because she was sick. She went to Urgent care, and they said it was suspicious of a delayed response to the vaccine. She said the symptoms were completely gone like the doctor suspected. She stated that doctor said it was good her temperature was going down but that she should follow up with Pfizer and would like to know if it was consistent with a delayed response. She was tested for COVID and the flu in which both were negative. The patient underwent lab tests and procedures which included sars-cov-2 test: negative, body temperature: 101 and flu test: negative on an unspecified date; Fever: 102.7 on 22Mar2021. The patient received Advil, Tylenol as treatment for adverse events. The outcome of event had a slight headache for a couple of days was recovered on 12Mar2021, a sore arm for a few days was recovered on an unspecified in Mar2021 and the outcome of the event she had a fever of 102.8 for a couple of days was recovered on 27Mar2021.    No follow-up attempts are needed. No further information is expected.
Received flu vaccine injection on 30 Aug 2012. Within 3 hours, top lip began swelling. By 31 Aug morning, angioedema to top lip - doubled in size. Received MEDROL dose pack (6 days). Allergic reaction.
Patient received Covid vaccination and was sitting in monitoring area. Patient reported to nurse she was feeling dizzy at 3:57pm. B/p 143/98 HR 109 Sat 99%. Patient pregnant, husband accompanying, Denies shortness of breath. States feel like heart fast, slightly diaphoretic. Allergies sulfa, metformin. 1602, ambulance called to clinic. 1606 HR 113, sat 99%, 1606b/p 156/101 hr 110, sat 99 %. 1609 ems on site, assumed care. Medical professional continue to monitor patient, vitals improved and sat remained greater than 95%. pt discharged in care of husband
Initial report received from a health care professional on 27 Oct 2010: On 26 Oct 2010, this patient received a intramuscular dose of only MenCYW-135 liquid conjugate component of MENVEO (batch number 091101), (dose unknown). The patient did not receive MenA lyophilized conjugate component of MENVEO. No adverse effect occurred. The outcome of the event was not reported.
Hives & itching to face & back 1/2 dose childrens' Benadryl given once
pt recvd vax & @ some time in the past several months had a sz;pt now has a sz disorder;being tx w/sound wave therapy;MD feels sz caused by pertussis component of vaccine;names of MD & pt are unk
4 days after first shot i became sick; swelling in wrist; swelling in knees; nausea; chills; headache; feeling unwell; This is a spontaneous report from a contactable consumer (who is also the patient, reported for self).   A 67-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VAC-CINE; Formulation: solution for injection; Batch/Lot Number: EL9269; Expiration date: UNKNOWN), via an unspecified route of administration in Left arm on 13Feb2021 as single dose for COVID-19 immunisation. The patient also received second dose via unspecified route of administration in left arm on 06Mar2021 (Batch/Lot Number: EN6203). The patient medical history was not reported. Patient had No known allergies. The patient received other medications (unspecified) in two weeks. The patient received no other vaccine in four weeks. The patient was not tested for COVID prior to vaccination.   It was reported that 4 days after first shot patient became sick swelling in wrist knees nausea chills headache feeling unwell on 17Feb2021. Adverse event resulted in doctor or other healthcare professional office/clinic visit. Patient did not received treatment for the adverse events. The patient was tested for COVID post vaccination. The patient underwent lab tests and procedures which included Qualitative PCR (Nasal Swab) sars-cov-2 test: unknown result on 26Feb2021. Outcome of all the events, sick swelling in wrist knees nausea chills headache feeling unwell was reported as not recovered.  No follow-up attempts are possible. No further information is expected.
The day following the 4th COVID-19 vaccination, patient developed a burning sensation of her bilateral eyes and subsequently developed bilateral blurry vision prompting her to present to the emergency department for evaluation. The patient evaluated by two physicians and diagnosed with uveitis. She started on neomycin-polymyxin-dexamethasone drops and referred to ophthalmology for close follow-up/re-evaluation.
where he broke the skin with a nail that was a little rusty; This is a spontaneous report from a contactable consumer (patient). A 77-year-old male patient received first single dose of BNT162B2 (Solution for injection, lot number: GL3249, exp date not reported) , intramuscular on 09Jan2021 12:00 for COVID-19 immunization; and tetanus vaccine, intramuscular (anatomical location: right arm) on 25Jan2021 at unspecified dose/frequency as tetanus shot. Patient received his first COVID shot at a Hospital. Patient had no relevant medical history. There were no concomitant medications. The patient was due for his second shot this Saturday, 30Jan2021. Patient went to a physician's office to receive a tetanus shot on Monday, 25Jan2021. On the same date (25Jan2021), he had a little incident where he broke the skin with a nail that was a little rusty.  He was wondering if that was an inhibitor to the vaccine. Patient wanted to know and or have a heads up if getting the Tetanus shot will cause him to have to reschedule his second COVID-19 vaccine. No Emergency Room visit required for the events. No relevant test/s performed. The outcome of events was unknown.
Nurse gave COVID vaccine at age 11. He has no adverse reactions and family was informed to get second dose after his birthday on 7/30.
MMR vaccine was expired on 3/20/20 and given. Parents notified and will return at a later date for another MMR.
Mild flu-like symptoms; This is a spontaneous report from a contactable consumer or other non hcp. A 66-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 05Feb2021 12:00 (at the age of 66 years old) (Batch/Lot Number: EL3247) as single dose, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 14Jan2021 15:45 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history includes hypersensitive reactions. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient has allergies to medications, food, or other products. The patient received medication within 2 weeks. On 05Feb2021 at 20:00 the patient experienced mild flu-like symptoms. No treatment was received for the adverse event. The reporter considered the events as non-serious. Outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
CT chest scan found blood clots in the vessels of the lungs and inflammation in the lymphatic area outside of the lung lobes.
hot flashes; body aches,; nausea at work; little bit of chills (no fever); stomach ache; she had an in and out headache; felt half decent,; she felt dizzy; her arm hurt a little bit; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (felt half decent,), DIZZINESS (she felt dizzy), PAIN IN EXTREMITY (her arm hurt a little bit), HOT FLUSH (hot flashes) and ABDOMINAL PAIN UPPER (stomach ache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included FLUOXETINE, PANTOPRAZOLE and IBUPROFEN for an unknown indication.    On 08-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Oct-2021, the patient experienced VACCINATION COMPLICATION (felt half decent,), DIZZINESS (she felt dizzy) and PAIN IN EXTREMITY (her arm hurt a little bit). On 10-Oct-2021, the patient experienced HEADACHE (she had an in and out headache). On 11-Oct-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), NAUSEA (nausea at work) and CHILLS (little bit of chills (no fever)). On 12-Oct-2021, the patient experienced HOT FLUSH (hot flashes) and MYALGIA (body aches,). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (felt half decent,), DIZZINESS (she felt dizzy), PAIN IN EXTREMITY (her arm hurt a little bit), HOT FLUSH (hot flashes), ABDOMINAL PAIN UPPER (stomach ache), HEADACHE (she had an in and out headache), NAUSEA (nausea at work), CHILLS (little bit of chills (no fever)) and MYALGIA (body aches,) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Moderna COVID-19 Vaccine  .   March 25 fever peak 102.5, groin lymph sore, body ache,weak. March 26- weak, body ache, left ankle can't bear weight, lower back pain. March 27- tired, diarrea and extreme lower back pain during night.  I feared paralysis.   March 28- extreme lower back pain.  Diarrea.  Fatigue. Hardly able to move due to back pain.  Began taking advil.  Improved mobility over the day using Advil. March 29 - continued back pain, fatigue, and limited movement.  Treating with Advil, I phoned my primary physician. March 30 - continued back pain, fatigue and limited movement - treating with Advil
Lingering aches and pain since receiving the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Lingering aches and pain since receiving the 1st dose) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced PAIN (Lingering aches and pain since receiving the 1st dose). At the time of the report, PAIN (Lingering aches and pain since receiving the 1st dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant product was provided by the reporter.   It was reported that the patient went to the doctor in Nov-2020 for a check-up and was not having any pain.  No treatment medication was provided.   This case was linked to MOD-2022-512683, MOD-2022-512678 (Patient Link).
Narrative:  Pt was on unit as inpatient for rehab post stroke when he contracted  COVID due to outbreak on the unit. He was transferred to other unit for isolation. Pt had  mild nasal congestion the day he was diagnosed, but was otherwise asymptomatic  throughout his COVID course. He did receive Cas/lmde mabs, and was later  transferred back to unit to reinstate rehabilitation.
Swollen and itchy hands, difficult to make a fist, hands feel tight. Patient took Ibuprofen and saw some improvement overnight. Hands still show some swelling roughly 20 hours post vaccination.
Information has been received from a physician concerning a 15 year old female who on 05-JUN-2009 was vaccinated with VARIVAX (Merck) (lot#, route and site of administration not reported). On 05-JUN-2009 the patient developed extremely swollen arm from the shoulder down to the elbow right after getting the vaccine. Unspecified medical attention was sought. At the time of reporting the patient was recovering. This is one of several cases from the same source. Additional information has been requested.
Patient received Pfizer monovalent instead of Pfizer bivalent as a Covid-19 booster.
24 hours after the vaccination on 05/19 the patients back started itching. She went home and her husband looked at it and she had rash. The following day on 05/20 her rash spread to her abdomen and continued itching. She then went to urgent care where she was diagnosed with shingles and given prescriptions for shingles treatment.
Patient had a febrile seizure the evening following vaccination. He had full body seizure activity for approximately 1 minute followed by a postictal state. He was taken by ambulance to the emergency room where a head CT, flu test, and strep test were all found to be normal. He had a documented temperature of 101 en route to the hospital.
Pt recv vax on 12/9/98; on 12/10/98 pt exp rash on legs, arms, back; swelling of joints w/ aching
This spontaneous report as received from a healthcare worker, practice manager refers to a unknown patients of unknown age and gender. On an unknown date the patients were vaccinated with ZOSTAVAX (dose and route not provided). The health care worker reported, the storage compartments that contained ZOSTAVAX were not monitored at all form 03-MAY-2014 until the report time. Doses of the vaccines that were exposed to unknown temperatures were administered to unspecified patients. The practice manager will provide the names of the patients who received doses of the un-monitored vaccines in during the period of time from 03-MAY-2013 until the present. The reporter stated that her practice has not been informed of any adverse experiences. No additional information was provided. This id one of several reports from the same source. Additional information has been requested.
Patient called on 10/14/2022 to report a reaction to the flu vaccine on 10/7/2022. Patient received a vaccine at a Flu Clinic around 11:50am and starting having aching and swelling in the left wrist around 12:05pm that lasted less than 36 hours. Patient stated her wrist bruised after the swelling and is still a little yellow today.
Patient received first dose of Moderna COVID vaccine and then developed a reaction called inflammatory ophthalmitis. Was admitted in hospital and treated with high dose prednisone. Is improving and being followed by eye clinic.
GUILLAIN BARRE SYNDROME; This spontaneous report received from a parent via a company representative via social media concerned a 30 year old female of unknown race and ethnicity. Initial information was processed along with the additional information received on 06-FEB-2022. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported,1 total, for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient was paralyzed and on 14-JAN-2022 diagnosed with guillain barre syndrome. It was reported that "my daughter 30 years of age was diagnosed with Gillian Barre Sindrome on 14th of January and she is Paralized" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of guillain barre syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220210517-COVID-19 VACCINE AD26.COV2.S-guillain barre syndrome. This event(s) is labeled per RSI and is therefore considered potentially related.
Anthrax #2 large local reaction 95mm x 100mm, erythema and warm to touch. Pt also had local reaction to #3 anthrax but half the size, even with pre-tx. 24hrs post anthrax#2, left arm had sore burning, itching and pain immediately afterwards. No fever, chills, NGV, no throat swelling or SOB, no hives or generalized pruritus, no PMH. Cloelasol, Allegra, Motrin, given.
fever 101.7; weakness, fatigue, dizzy, muscle soreness, swelling @ site of inj the size of a tennis ball, redness, tenderness;
Received vaccines 4/20/2020. Later that afternoon/evening, developed a generalized tonic clonic seizure. Lasted about 1 minute, post-ictal x 20-30 minutes after. Temperature taken at time of seizure and was 97.8. A few hours later was 100.2, never got higher. No other viral symptoms, no further temperature elevations. Fully back to baseline within a few hours. Has had 5 febrile seizures (each in setting of fever 101 or greater) in the past. Had normal brain MRI and EEG in 2/2020.
Past 42 days for 2nd dose; A spontaneous report was received from a consumer concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) with more than 42 days between doses.   The patient's medical history, concomitant history, lab data was not provided by the reporter.  On 19.Jan.2021,  the patient received the first of two planned doses of mRNA-1273 (Lot number:unknown) intramuscularly for prophylaxis of COVID-19 infection.  The patient was never scheduled for 2nd dose. Grand daughter tried to call the facility who administered the 1st dose in order to schedule the 2 nd dose.she was unable to get hold of anyone  Action taken with mRNA-1273 in response to the events was not provided/unknown  The  outcome of the event, more than 42 days between doses, was considered as considered recovered/resolved on an unknown date.; Reporter's Comments: This report refers to a case of  Inappropriate schedule of product administration for mRNA-1273 ,lot #unknown ,with no associated AEs.
A rash appeared at the injection site. It was red and itchy. It covered a large portion of the upper, left arm and it went around the arm. The rash was larger than my hand. This appeared 2 weeks after the first injection.
PCV 20 given to 2mo old, PCV15 indicated. No adverse effects currently
30MAY92-2JUN92 progressive fever 104-106, went to ER 2JUN92 w/fever of 106 Amoxicillin given; 3JUN92 appearance of fine red dots on chest, changed ATB; rash dec & faded;
began spontaneous hemolysis due to cold agglutinatin with cryoglobulin proteins present
After a family gathering on 12/26/2022 following evening I began having symptoms of a chest cold. Following day I developed a minor sore throat with congestion that lasted several days. After the congestion and sore throat subsided but I was still felt the chest cold. I started feeling better for a week, then 1 week later started feeling fatigue and the chest cold again. Had appointment with online urgent care doctor and was prescribed prednisone, albuterol inhaler, and ADVAIR inhaler and a ZPAK. Only took ZPAK and ADVAIR inhaler. Started feeling better after 5 day course of ZPAK, but was left with a dry cough.
Pt developed right facial Bell's Palsy 26 days post vax. Pt was treated with 7 day course of oral prednisone therapy beginning 03/28/2001; physical therapy began 04/03/2001.
On 6/17/00, onset 13:00, the pt gazed off, left hand twitched and when picked up his legs began twitching, lasting about 30 seconds. Then he went to sleep. He had crying, was irritable and moaning. Dx: Febrile seizure with fever of 102.5, post vax.
I previously tested positive for COVID on 11/4/20. I had fever, chills, feeling of being very cold, cough, headache, rigors, fatigue, nausea, dizziness and was slightly short of breath one night. I recovered within two or so weeks. I was not hospitalized.  I recieved my first dose COVID Pfizer vaccination on Tuesday, 4/13/21 at 1:10PM. On 4/16/21, I woke up around 8:00AM with blurred vision. I took out my contacts three separate times because I was convinced I kept putting them in wrong. As I was staring at the computer, my vision was very blurry and distorted. That night, I went to dinner with my father, a few other family members and friends. I kept remarking how my vision was blurry.
Symptoms: 1. hives, blisters, itching - comes & goes Suspect Drug #1 Dosing: not sure from this or sulfa/trimethoprim po.
Immediate pain upon injection (upper left shoulder at top of shoulder), red/swelling/hot at  injection site, muscle pains in various parts of the body, upset stomach, followed by hotness of neck and ears. Required ice on injection site to calm down injection site. Two days later, still have injection site pain.
right arm really started hurting which was throbbing; Skin under armpit feels dull after 1st dose; Shooting pain on skin after 1st dose; Arm feels heavy after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (right arm really started hurting which was throbbing), SKIN DISCOMFORT (Skin under armpit feels dull after 1st dose), PAIN OF SKIN (Shooting pain on skin after 1st dose) and LIMB DISCOMFORT (Arm feels heavy after 1st dose) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013a21a) for COVID-19 vaccination.     No medical history reported.     On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (right arm really started hurting which was throbbing), SKIN DISCOMFORT (Skin under armpit feels dull after 1st dose), PAIN OF SKIN (Shooting pain on skin after 1st dose) and LIMB DISCOMFORT (Arm feels heavy after 1st dose). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (right arm really started hurting which was throbbing), SKIN DISCOMFORT (Skin under armpit feels dull after 1st dose), PAIN OF SKIN (Shooting pain on skin after 1st dose) and LIMB DISCOMFORT (Arm feels heavy after 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment medications included Tylenol and Aleve.
Administration error: Vaccinator: diluted 5-11 year Pfizer with 1.8mL of saline instead of 1.3mL and administered 0.3mL intramuscular deltoid.